HTG Molecular Diagnostics, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-02-10: Reporting owner Barat Stephen; Form 3; Security Stock Option (right to buy); Transaction Holding.
- 2023-02-10: Reporting owner Barat Stephen; Form 3; Security Stock Option (right to buy); Transaction Holding.
- 2022-09-15: Reporting owner KIRITSY CHRISTOPHER P; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-09-15: Reporting owner GRIFFIN MICHELLE RENEE; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-02-10 holding as of filing | Barat Stephen Officer (Senior VP of Therapeutics) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $62.41 exercise price | 2023-02-10 | ||
| 2023-02-10 holding as of filing | Barat Stephen Officer (Senior VP of Therapeutics) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $11.28 exercise price | 2023-02-10 |